Respiratory Sciences builds a portable device and cloud‑based software platform that captures high‑fidelity lung function data and applies advanced analytics to detect early signs of asthma, COPD, and other respiratory diseases. The system delivers clinicians actionable risk scores, treatment recommendations, and remote monitoring capabilities that integrate with electronic health records for proactive, personalized patient care.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with asthma, COPD, and other respiratory conditions often receive diagnoses and monitoring only after symptoms have progressed, limiting opportunities for early intervention and personalized treatment.
Solution
Respiratory Sciences is developing a combined hardware device and software platform that captures detailed respiratory measurements and applies advanced analytics to identify early signs of disease. The system provides clinicians with actionable insights to tailor treatment plans and track patient progress over time. By enabling more frequent, objective assessments outside of traditional clinic visits, the platform supports proactive disease management and improves patient outcomes. The solution is designed to integrate with existing care workflows, offering a seamless interface for data review and care coordination.
Target Audience
Primary customers are pulmonologists, primary care physicians, and respiratory therapy clinics that manage patients with asthma, COPD, and related respiratory disorders.
Features
- Portable respiratory measurement device that records lung function metrics with high fidelity
- Cloud‑based analytics engine that processes raw data to detect early disease markers
- Interpretive software dashboard delivering personalized risk scores and treatment recommendations
- Remote monitoring capability allowing patients to perform assessments at home and sync results securely
- Integration APIs for electronic health record systems to streamline data flow into clinical workflows